look at the days to cover, its down to 3. the stock has become a daily trade, that why the number of shorts is so high. Also at least 200k is from that Kerrisdale guy
I got the same exact reply, but hey at least its to some extend substantial.
You went 100k margin on a 25k account for 2k profit? No wonder you guys are losing money. Ever heard of risk management.
He was talking about Abraxis Bioscience which was acquired by Celgene in 2010 for 2.9B. They had around 300 milion in rev and 88% of that revenue was from that medicine he compared to.
Frank, how about you GTFO you troll and stop spreading misinformation.
Sorry, but even if they go long it might only hit 3 for a short time. Plenty of support built around that area.
One more quote:
"Yeah like I said that should be a matter of weeks and I mean maybe three or four weeks and it could even be quicker depending on how quickly people firm up their offer. So they met everyone involved knows that we are going to move fairly rapidly. We need to do our own planning and complete our size and structure and we have different scenarios in place and Scott certainly prepared to deal with either pathway.
Having said that we also need time to execute on the go alone strategy. So everyone involved knows that we can't take a long time for them to finalize their offer and if for example we have no offers which is not the expected outcome we're fully prepared anyway to move forward and launch this product on our own at our launch meeting at the end of February or first week of March, we'll be there one way or another. - See more at:"
This is what Roger said:
"So we -- as you suggested, we know there are outside interests in co-promoting the product, we'll as quickly as possible and I would say, that's in a matter of weeks not months be both receiving final proposals and reviewing those and then discussing them with our Board it's our intention to make a quick decision and then to move forward with the detailed planning and implementations. So again we think we are well prepared, we have had a number of discussions along the way.
We know the companies that have been interested and we think we will have some interesting discussions and some interesting choices to make."
"Well first off, I mean all product launches I am sure you guys -- this is not different than any others -- we're going to have a team of around 150 representatives. We use a number of around $225,000 per and that includes the absorption of management et cetera these launches have some unusual cost that you don't see in many launches and that's around the rims and the monitoring and safe use initiatives that we will be doing but you also don't have samples, you don't have direct-to-consumer, advertising and so these are reasonable levels of investment and expenditure and very easy to quantify. So the thing about the need of capital is the very first decision that we need to make is are we going to partner or not? Because that really hits us two ways and that is there would be some money upfront and then our cost structure would be split or shared differently than if we go alone.
So all of those impact the amount of capital that we would need. If we go alone, if you will we know the amount of money that we need. We haven't disclosed what that is but I would say it's a modest sum. And as soon as we make the decisions about partnering or not we'll be talking about that in more detail."
So basically he is saying we will know and they will let us know sometimes after the board meeting.